'You never told me I would turn into a gambler': a first person account of dopamine agonist--induced gambling addiction in a patient with restless legs syndrome
- PMID: 22678941
- PMCID: PMC3171036
- DOI: 10.1136/bcr.07.2011.4459
'You never told me I would turn into a gambler': a first person account of dopamine agonist--induced gambling addiction in a patient with restless legs syndrome
Abstract
Dopaminergic agents are commonly used and effective treatments for restless legs syndrome (RLS), a disabling sensorimotor disorder. Less known are some of the potentially disabling side effects of these treatments, particularly iatrogenic gambling addiction, as is described here. Here the authors present a 62-year-old man, with a 20-year history of RLS, who developed gambling addiction while on dopaminergic treatment. He was not forewarned of this side effect, nor was he ever screened for gambling behaviours prior to or during treatment. Eight months after discontinuation of dopaminergic treatment and after 10 sessions of cognitive-behavioural therapy for gambling addiction, his gambling behaviours have partially resolved. To our knowledge, this is the first ever first person account of this condition. To prevent the devastating consequences of gambling addiction or to minimise its impact by early intervention, the authors call for clinicians involved in treatment of RLS to follow these simple measures: screen patients for gambling behaviours prior to the onset and during dopaminergic treatment; forewarn patients of this potential side effect; and if patients screen positive, refer them to specialist gambling treatment services, in addition to making necessary changes to their medication regime.
Conflict of interest statement
Similar articles
-
[Pathological gambling induced by dopamine agonists].Fortschr Neurol Psychiatr. 2011 Aug;79(8):470-4. doi: 10.1055/s-0031-1281580. Epub 2011 Aug 1. Fortschr Neurol Psychiatr. 2011. PMID: 21809260 German.
-
Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044. Sleep. 2013. PMID: 24082309 Free PMC article.
-
ADMET considerations for restless leg syndrome drug treatments.Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1247-61. doi: 10.1517/17425255.2012.708023. Epub 2012 Jul 18. Expert Opin Drug Metab Toxicol. 2012. PMID: 22808933 Review.
-
Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.Eur J Neurol. 2013 Sep;20(9):1241-6. doi: 10.1111/ene.12001. Epub 2012 Oct 22. Eur J Neurol. 2013. PMID: 23083216
-
Treatment of Parkinson's disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist.Int J Clin Pract. 2002 Jul-Aug;56(6):468-74. Int J Clin Pract. 2002. PMID: 12166546 Review.
Cited by
-
Restless legs syndrome: Over 50 years of European contribution.J Sleep Res. 2022 Aug;31(4):e13632. doi: 10.1111/jsr.13632. Epub 2022 Jul 9. J Sleep Res. 2022. PMID: 35808955 Free PMC article. Review.
-
Dopamine Agonists and Impulse Control Disorders: A Complex Association.Drug Saf. 2018 Jan;41(1):19-75. doi: 10.1007/s40264-017-0590-6. Drug Saf. 2018. PMID: 28861870 Free PMC article. Review.
-
Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.J Clin Sleep Med. 2019 Sep 15;15(9):1225-1232. doi: 10.5664/jcsm.7908. J Clin Sleep Med. 2019. PMID: 31538593 Free PMC article.
-
Treatment of harmful gambling: a scoping review of United Kingdom-based intervention research.BMC Psychiatry. 2024 May 23;24(1):392. doi: 10.1186/s12888-024-05843-8. BMC Psychiatry. 2024. PMID: 38783231 Free PMC article.
References
-
- Högl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 2005;64:1920–4 - PubMed
-
- Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101–19 - PubMed
-
- Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical update. Chest 2006;130:1596–604 - PubMed
-
- Pourcher E, Rémillard S, Cohen H. Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci 2010;290:52–6 - PubMed
-
- Quickfall J, Suchowersky O. Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord 2007;13:535–6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous